Revision History

A 39-year-old Los Angeles mother diagnosed with Stage 4 colorectal cancer that had spread to her liver now shows no evidence of disease three months after receiving a living donor liver transplant at Northwestern Medicine in Chicago. Her case is part of a growing body of clinical evidence — including landmark European trials showing 5-year survival rates as high as 83% — that is challenging long-held assumptions about transplant eligibility and offering new hope for patients with what was previously considered an untreatable condition.